Cargando…

Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series

Chronic hepatitis B virus (HBV) infection is one of the most common causes of hepatocellular carcinoma (HCC), a malignant tumor with high mortality worldwide. One remarkable clinical feature of HBV-related HCC is that the risk of development is higher in males and postmenopausal females compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashir Hamidu, Rukaiya, Chalikonda, Divya M., Hann, Hie-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402514/
https://www.ncbi.nlm.nih.gov/pubmed/34451963
http://dx.doi.org/10.3390/vaccines9080838
_version_ 1783745808144793600
author Bashir Hamidu, Rukaiya
Chalikonda, Divya M.
Hann, Hie-Won
author_facet Bashir Hamidu, Rukaiya
Chalikonda, Divya M.
Hann, Hie-Won
author_sort Bashir Hamidu, Rukaiya
collection PubMed
description Chronic hepatitis B virus (HBV) infection is one of the most common causes of hepatocellular carcinoma (HCC), a malignant tumor with high mortality worldwide. One remarkable clinical feature of HBV-related HCC is that the risk of development is higher in males and postmenopausal females compared to other females. Increasing evidence also indicates that the prognosis of HBV-associated HCC may involve gender disparity, with females having more favorable outcomes. The proposed mechanism of this gender disparity is thought to be complex and multifactorial. Attributions have been made to gender differences in behavioral risk factors, host stress, immune response, psychology, metabolic risk factors, tumor biology, and hormonal factors. Gender disparities in hormonal factors and stress with consequent incited inflammation and hepatocarcinogenesis in HBV-related HCC is a particularly burgeoning area of investigation. Clarifying these mechanisms could provide insight into HBV-related HCC pathogenesis, and potentially provide a target for prevention and treatment of this disease. Reported herein is a case series involving two families affected by vertically transmitted chronic hepatitis B, longitudinally observed over multiple decades, with family members demonstrating discordant outcomes related to HCC, with worse outcomes among affected males. As a supplement to this case, we review the currently available literature on gender differences in outcomes from HBV-related HCC. In reporting this case series, we aim to add our important observation to the current literature and highlight the need for further research in the mechanisms involved in gender disparity in the prognosis of HBV-related HCC.
format Online
Article
Text
id pubmed-8402514
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84025142021-08-29 Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series Bashir Hamidu, Rukaiya Chalikonda, Divya M. Hann, Hie-Won Vaccines (Basel) Review Chronic hepatitis B virus (HBV) infection is one of the most common causes of hepatocellular carcinoma (HCC), a malignant tumor with high mortality worldwide. One remarkable clinical feature of HBV-related HCC is that the risk of development is higher in males and postmenopausal females compared to other females. Increasing evidence also indicates that the prognosis of HBV-associated HCC may involve gender disparity, with females having more favorable outcomes. The proposed mechanism of this gender disparity is thought to be complex and multifactorial. Attributions have been made to gender differences in behavioral risk factors, host stress, immune response, psychology, metabolic risk factors, tumor biology, and hormonal factors. Gender disparities in hormonal factors and stress with consequent incited inflammation and hepatocarcinogenesis in HBV-related HCC is a particularly burgeoning area of investigation. Clarifying these mechanisms could provide insight into HBV-related HCC pathogenesis, and potentially provide a target for prevention and treatment of this disease. Reported herein is a case series involving two families affected by vertically transmitted chronic hepatitis B, longitudinally observed over multiple decades, with family members demonstrating discordant outcomes related to HCC, with worse outcomes among affected males. As a supplement to this case, we review the currently available literature on gender differences in outcomes from HBV-related HCC. In reporting this case series, we aim to add our important observation to the current literature and highlight the need for further research in the mechanisms involved in gender disparity in the prognosis of HBV-related HCC. MDPI 2021-07-30 /pmc/articles/PMC8402514/ /pubmed/34451963 http://dx.doi.org/10.3390/vaccines9080838 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bashir Hamidu, Rukaiya
Chalikonda, Divya M.
Hann, Hie-Won
Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
title Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
title_full Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
title_fullStr Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
title_full_unstemmed Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
title_short Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
title_sort gender disparity in host responses to hepatitis b-related hepatocellular carcinoma: a case series
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402514/
https://www.ncbi.nlm.nih.gov/pubmed/34451963
http://dx.doi.org/10.3390/vaccines9080838
work_keys_str_mv AT bashirhamidurukaiya genderdisparityinhostresponsestohepatitisbrelatedhepatocellularcarcinomaacaseseries
AT chalikondadivyam genderdisparityinhostresponsestohepatitisbrelatedhepatocellularcarcinomaacaseseries
AT hannhiewon genderdisparityinhostresponsestohepatitisbrelatedhepatocellularcarcinomaacaseseries